The Role of the Immune System in Nevirapine-Induced Subclinical Liver Injury of a Rat Model
Figure 5
An illustration of the possible subclinical immune-pathological changes in the liver during treatment with nevirapine in rats over the 21 days. NVP: nevirapine, RNM: reactive nevirapine metabolites, PA: protein adducts, NK: natural killer cells, and MØ: macrophage.
